Exchange: NASDAQ·Updated 03:57 PM EDT
PHAR logo

PHAR Pharming Group

$11.70
$0.08
(0.68%)
Today
EarningsNov 5
Mkt Cap$828.1M
Vol9,446.00

About PHAR

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
47

Neutral Sentiment

How do you feel about PHAR?

Advertisement|Remove ads.